The development of neurocritical care in China from the perspective of evaluation and treatment of critical neurological diseases
ObjectiveTo understand the varieties, evaluation, treatment, and prognosis of severe neurological diseases using the third NCU survey in China.DesignA cross-sectional questionnaire study. The study was completed in three main steps: filling in the questionnaire, sorting out the survey data, and anal...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-02-01
|
| Series: | Frontiers in Neurology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2023.1114204/full |
| _version_ | 1797901475386490880 |
|---|---|
| author | Yingying Su Junfang Teng Fei Tian Jing Jing Huijin Huang Suyue Pan Wen Jiang Furong Wang Le Zhang Yan Zhang Meng Zhang Liping Liu Jie Cao Huaiqiang Hu Wei Li Cheng Liang Liansheng Ma Xuegang Meng Linyu Tian Changqing Wang Lihua Wang Yan Wang Zhenhai Wang Zhiqiang Wang Zunchun Xie Mingyao You Jun Yuan Chaosheng Zeng Li Zeng Lei Zhang Xin Zhang Yongwei Zhang Bin Zhao Saijun Zhou Zhonghe Zhou |
| author_facet | Yingying Su Junfang Teng Fei Tian Jing Jing Huijin Huang Suyue Pan Wen Jiang Furong Wang Le Zhang Yan Zhang Meng Zhang Liping Liu Jie Cao Huaiqiang Hu Wei Li Cheng Liang Liansheng Ma Xuegang Meng Linyu Tian Changqing Wang Lihua Wang Yan Wang Zhenhai Wang Zhiqiang Wang Zunchun Xie Mingyao You Jun Yuan Chaosheng Zeng Li Zeng Lei Zhang Xin Zhang Yongwei Zhang Bin Zhao Saijun Zhou Zhonghe Zhou |
| author_sort | Yingying Su |
| collection | DOAJ |
| description | ObjectiveTo understand the varieties, evaluation, treatment, and prognosis of severe neurological diseases using the third NCU survey in China.DesignA cross-sectional questionnaire study. The study was completed in three main steps: filling in the questionnaire, sorting out the survey data, and analyzing the survey data.ResultsOf 206 NCUs, 165 (80%) provided relatively complete information. It was estimated that 96,201 patients with severe neurological diseases were diagnosed and treated throughout the year, with an average fatality rate of 4.1%. The most prevalent severe neurological disease was cerebrovascular disease (55.2%). The most prevalent comorbidity was hypertension (56.7%). The most prevalent complication was hypoproteinemia (24.2%). The most common nosocomial infection was hospital-acquired pneumonia (10.6%). The GCS, APACHE II, EEG, and TCD were the most commonly used (62.4–95.2%). The implementation rate of the five nursing evaluation techniques reached 55.8–90.9%. Routinely raising the head of the bed by 30°, endotracheal intubation and central venous catheterization were the mostprevalent treatment strategies (97.6, 94.5, and 90.3%, respectively). Traditional tracheotomy, invasive mechanical ventilation and nasogastric tube feeding (75.8, 95.8, and 95.8%, respectively) were more common than percutaneous tracheotomy, non-invasive mechanical ventilation and nasogastric tube insertion (57.6, 57.6, and 66.7%, respectively). Body surface hypothermia brain protection technology was more commonly used than intravascular hypothermia technology (67.3 > 6.1%). The rates of minimally invasive hematoma removal and ventricular puncture were only 40.0 and 45.5%, respectively.ConclusionIn addition to traditional recognized basic life assessment and support technology, it is necessary to the use of promote specialized technology for neurological diseases, according to the characteristics of critical neurological diseases. |
| first_indexed | 2024-04-10T09:01:32Z |
| format | Article |
| id | doaj.art-d161606fc52a42dd8b925882abe532c9 |
| institution | Directory Open Access Journal |
| issn | 1664-2295 |
| language | English |
| last_indexed | 2024-04-10T09:01:32Z |
| publishDate | 2023-02-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Neurology |
| spelling | doaj.art-d161606fc52a42dd8b925882abe532c92023-02-21T13:43:08ZengFrontiers Media S.A.Frontiers in Neurology1664-22952023-02-011410.3389/fneur.2023.11142041114204The development of neurocritical care in China from the perspective of evaluation and treatment of critical neurological diseasesYingying Su0Junfang Teng1Fei Tian2Jing Jing3Huijin Huang4Suyue Pan5Wen Jiang6Furong Wang7Le Zhang8Yan Zhang9Meng Zhang10Liping Liu11Jie Cao12Huaiqiang Hu13Wei Li14Cheng Liang15Liansheng Ma16Xuegang Meng17Linyu Tian18Changqing Wang19Lihua Wang20Yan Wang21Zhenhai Wang22Zhiqiang Wang23Zunchun Xie24Mingyao You25Jun Yuan26Chaosheng Zeng27Li Zeng28Lei Zhang29Xin Zhang30Yongwei Zhang31Bin Zhao32Saijun Zhou33Zhonghe Zhou34Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, ChinaDepartment of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaDepartment of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, ChinaDepartment of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaDepartment of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, ChinaDepartment of Neurology, Nanfang Hospital of Southern Medical University, Guangzhou, ChinaDepartment of Neurology, Xijing Hospital Fourth Military Medical University, Xi'an, ChinaDepartment of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Neurology, Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, ChinaDepartment of Neurology, Daping Hospital, The Army Military Medical University, Chongqing, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Neurology, The First Hospital of Jilin University, Changchun, China0Department of Neurology, The 960(th) Hospital of Joint Logistics Support, PLA, Jinan, ChinaDepartment of Neurology, Daping Hospital, The Army Military Medical University, Chongqing, China1Department of Neurology, The Second Hospital of Lanzhou University, Lanzhou, China2Department of Neurology, The First Hospital of Shanxi Medical University, Taiyuan, China3Department of Neurology, The Xinjiang Uygur Autonomous Region People's Hospital, Urumqi, China4Department of Neurology, West China Hospital, Sichuan University, Chengdu, China5Department of Neurology, The First Affiliated Hospital of Anhui Medical University, Hefei, China6Department of Neurology, The Second Affiliated Hospital, Harbin Medical University, Harbin, China7Department of Neurology, Tangshan People's Hospital of Hebei Province, Tangshan, China8Neurology Center, General Hospital of Ningxia Medical University, Yinchuan, China9Department of Neurology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China0Department of Neurology, The First Affiliated Hospital of Nanchang University, Nanchang, China1Department of Neurology, The Affiliated Hospital of Guizhou Medical University, Guiyang, China2Department of Neurology, Inner Mongolia People's Hospital, Hohhot, China3Department of Neurology, The Second Affiliated Hospital of Hainan Medical University, Haikou, China4Department of Neurology, The Affiliated Hospital of Guangxi Medical University, Nanning, China5Department of Neurology, The First People's Hospital of Yunnan Province, Kunming, China6Department of Neurology, Nanjing Drum Tower Hospital, Nanjing, China7Department of Neurovascular Center, Changhai Hospital, Naval Medical University, Shanghai, China8Department of Neurology, Tianjin Medical University General Hospital, Tianjin, China9Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China0Department of Neurology, General Hospital of Northern Theater Command, Shenyang, ChinaObjectiveTo understand the varieties, evaluation, treatment, and prognosis of severe neurological diseases using the third NCU survey in China.DesignA cross-sectional questionnaire study. The study was completed in three main steps: filling in the questionnaire, sorting out the survey data, and analyzing the survey data.ResultsOf 206 NCUs, 165 (80%) provided relatively complete information. It was estimated that 96,201 patients with severe neurological diseases were diagnosed and treated throughout the year, with an average fatality rate of 4.1%. The most prevalent severe neurological disease was cerebrovascular disease (55.2%). The most prevalent comorbidity was hypertension (56.7%). The most prevalent complication was hypoproteinemia (24.2%). The most common nosocomial infection was hospital-acquired pneumonia (10.6%). The GCS, APACHE II, EEG, and TCD were the most commonly used (62.4–95.2%). The implementation rate of the five nursing evaluation techniques reached 55.8–90.9%. Routinely raising the head of the bed by 30°, endotracheal intubation and central venous catheterization were the mostprevalent treatment strategies (97.6, 94.5, and 90.3%, respectively). Traditional tracheotomy, invasive mechanical ventilation and nasogastric tube feeding (75.8, 95.8, and 95.8%, respectively) were more common than percutaneous tracheotomy, non-invasive mechanical ventilation and nasogastric tube insertion (57.6, 57.6, and 66.7%, respectively). Body surface hypothermia brain protection technology was more commonly used than intravascular hypothermia technology (67.3 > 6.1%). The rates of minimally invasive hematoma removal and ventricular puncture were only 40.0 and 45.5%, respectively.ConclusionIn addition to traditional recognized basic life assessment and support technology, it is necessary to the use of promote specialized technology for neurological diseases, according to the characteristics of critical neurological diseases.https://www.frontiersin.org/articles/10.3389/fneur.2023.1114204/fullcritical neurological diseaseevaluationtreatmentNCCUinvestigation |
| spellingShingle | Yingying Su Junfang Teng Fei Tian Jing Jing Huijin Huang Suyue Pan Wen Jiang Furong Wang Le Zhang Yan Zhang Meng Zhang Liping Liu Jie Cao Huaiqiang Hu Wei Li Cheng Liang Liansheng Ma Xuegang Meng Linyu Tian Changqing Wang Lihua Wang Yan Wang Zhenhai Wang Zhiqiang Wang Zunchun Xie Mingyao You Jun Yuan Chaosheng Zeng Li Zeng Lei Zhang Xin Zhang Yongwei Zhang Bin Zhao Saijun Zhou Zhonghe Zhou The development of neurocritical care in China from the perspective of evaluation and treatment of critical neurological diseases Frontiers in Neurology critical neurological disease evaluation treatment NCCU investigation |
| title | The development of neurocritical care in China from the perspective of evaluation and treatment of critical neurological diseases |
| title_full | The development of neurocritical care in China from the perspective of evaluation and treatment of critical neurological diseases |
| title_fullStr | The development of neurocritical care in China from the perspective of evaluation and treatment of critical neurological diseases |
| title_full_unstemmed | The development of neurocritical care in China from the perspective of evaluation and treatment of critical neurological diseases |
| title_short | The development of neurocritical care in China from the perspective of evaluation and treatment of critical neurological diseases |
| title_sort | development of neurocritical care in china from the perspective of evaluation and treatment of critical neurological diseases |
| topic | critical neurological disease evaluation treatment NCCU investigation |
| url | https://www.frontiersin.org/articles/10.3389/fneur.2023.1114204/full |
| work_keys_str_mv | AT yingyingsu thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT junfangteng thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT feitian thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT jingjing thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT huijinhuang thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT suyuepan thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT wenjiang thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT furongwang thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT lezhang thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT yanzhang thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT mengzhang thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT lipingliu thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT jiecao thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT huaiqianghu thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT weili thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT chengliang thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT lianshengma thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT xuegangmeng thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT linyutian thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT changqingwang thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT lihuawang thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT yanwang thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT zhenhaiwang thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT zhiqiangwang thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT zunchunxie thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT mingyaoyou thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT junyuan thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT chaoshengzeng thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT lizeng thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT leizhang thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT xinzhang thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT yongweizhang thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT binzhao thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT saijunzhou thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT zhonghezhou thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT yingyingsu developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT junfangteng developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT feitian developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT jingjing developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT huijinhuang developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT suyuepan developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT wenjiang developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT furongwang developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT lezhang developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT yanzhang developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT mengzhang developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT lipingliu developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT jiecao developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT huaiqianghu developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT weili developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT chengliang developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT lianshengma developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT xuegangmeng developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT linyutian developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT changqingwang developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT lihuawang developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT yanwang developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT zhenhaiwang developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT zhiqiangwang developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT zunchunxie developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT mingyaoyou developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT junyuan developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT chaoshengzeng developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT lizeng developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT leizhang developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT xinzhang developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT yongweizhang developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT binzhao developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT saijunzhou developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT zhonghezhou developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases |